1. Clinical trials report

   • John A. Farmer

   Report 15 February 2009 Pages: 81 - 83

2. Nicotinic acid: A new look at an old drug

   • John A. Farmer

   OriginalPaper 15 February 2009 Pages: 87 - 92

3. GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects

   • Melanie Sulistio
   • Curtis Carothers
   • Robert Chilton

   OriginalPaper 15 February 2009 Pages: 93 - 99

4. The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: Evidence from clinical trials

   • Alawi A. Alsheikh-Ali
   • Richard H. Karas

   OriginalPaper 15 February 2009 Pages: 100 - 104

5. Aspirin resistance: An update

   • Gilead I. Lancaster
   • Janardhan Srinivasan
   • Hitender Jain

   OriginalPaper 15 February 2009 Pages: 105 - 110

6. The role of CT angiography in risk stratification for atherosclerosis

   • Axel Schmermund
   • Annett Magedanz
   • Thomas Voigtländer

   OriginalPaper 15 February 2009 Pages: 111 - 117

7. The role of statin therapy in the management of cardiomyopathies

   • Kumudha Ramasubbu
   • John A. Farmer

   OriginalPaper 15 February 2009 Pages: 118 - 123

8. The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk

   • Fadi G. Hage
   • Alexander J. Szalai

   OriginalPaper 15 February 2009 Pages: 124 - 130

9. Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes

   • Carlos Gonzalez-Quesada
   • Nikolaos G. Frangogiannis

   OriginalPaper 15 February 2009 Pages: 131 - 138

10. Pulmonary arterial hypertension

    • Aydin Uzunpinar
    • Mehmet Cilingiroglu

    OriginalPaper 15 February 2009 Pages: 139 - 145

11. Drug-eluting stents and vulnerable plaque

    • Mehmet Cilingiroglu
    • Faisal Khan

    OriginalPaper 15 February 2009 Pages: 146 - 148

12. Lipid management: Considerations in acute coronary syndrome

    • Venkateshwar R. Polsani
    • Salim S. Virani
    • Vijay Nambi

    OriginalPaper 15 February 2009 Pages: 149 - 156